In a major relief to AstraZeneca, the Delhi High Court has granted summary judgment, confirming that Westcoast Pharmaceutical ...
Projected to be worth over $38 billion in the global healthcare market by 2032, AI simulations have the potential to ...
The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...
Researchers review the safety, efficacy, and considerations for COVID-19 vaccination in multiple sclerosis patients, ...
Trastuzumab deruxtecan is a targeted drug used to treat certain types of cancer: breast cancer, gastric or gastroesophageal ...
We recently published a list of 12 Best ADR Stocks To Invest In According to Analysts. In this article, we are going to take ...
Current global health developments include China's green light for foreign-owned hospitals, the addition of AstraZeneca's ...
Friday, November 29, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Chevron ...
The new 1.1 billion-yuan ($152 million) production facility in Shanghai will make antibody-drug conjugates, which use ...
First new treatment for asthma attacks in 50 years can reduce need for hospitalisation by 30 percent
Benralizamab is a monoclonal antibody which targets specific white blood cells, called eosinophils, to reduce lung ...
The U.S. pharmaceutical industry seeks to alter Medicare drug price negotiation laws under Trump's return. China approves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback